Cargando…
Combination Treatment with Irritant and Recombinant Interleukin 2 in the Peritoneal Cavity for Evoking Effective Anti‐tumor Activity: Generation of Lymphokine‐activated Killer Cells and Tumor‐specific Killer Cells
Meth A sarcoma, growing in the subcutaneous tissue of syngeneic BALB/c mice, regressed completely after an intraperitoneal (ip) injection of protease peptone (PP) (on day 6) followed by 2 ip administrations (on days 7 and 8) of human recombinant interleukin‐2 (IL‐2, 25 μg/day), whereas one such trea...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
1990
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918044/ https://www.ncbi.nlm.nih.gov/pubmed/2114394 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02584.x |